Roche Diabetes Care’s Michael Goetzl explains how the company is spearheading a combined digital-pharmaceutical approach to diabetes and how pharma firms can best embrace holistic strategies.

J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target ...

1 Day ROG -1.02% DJIA 0.59% S&P 500 0.38% Health Care/Life Sciences 2.54% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Digital health tools promise to make diabetes care more accessible, effective, and adaptable to patients' individual needs. Advancements in wearable devices, mobile applications, and telemedicine can ...

Researchers discover that capillary obstruction in diabetes, triggered by elevated interleukin-10 signaling, may contribute to cognitive deficits independent of blood sugar levels. Study ...

The winner of a competition to design a service logo, organised by the paediatric diabetes team at Hemel Hempstead Hospital, has won the judges over with a meaningful and imaginative design.

Nov. 7, 2024 — People who work the nightshift or odd hours and eat at irregular times are more prone to weight gain and diabetes, likely due to eating patterns not timed with natural daylight ...

Treating Obesity: Confronting a New Normal: Food Is Medicine A physician trades his primary care practice for a farm to provide chronically ill, obese patients with optimal nutrition, recognizing ...

IPC Indice de Precios Y Cotizaciones 52,311.08 578.62 1.12% ...